Research theme for competitive and other funds (1):
2022 - 2025 データ駆動型医療により高齢者心不全診療の質を向上する補助ツールの開発
Papers (10):
Takaya Sasaki, Kensuke Izumaru, Jun Hata, Satoko Sakata, Emi Oishi, Takuya Nagata, Nobuo Tsuboi, Yoshinao Oda, Takanari Kitazono, Takashi Yokoo, et al. Serum NT-proBNP levels and histopathological myocardial fibrosis in autopsied cases from a Japanese community: The Hisayama Study. Journal of cardiology. 2021. 78. 3. 237-243
Tomoko Yoshikawa, Jun Hata, Satoko Sakata, Takuya Nagata, Yoichiro Hirakawa, Yoshitaka Hirooka, Hiroyuki Tsutsui, Takanari Kitazono, Toshiharu Ninomiya. Serum High-Sensitivity C-Reactive Protein Levels and the Development of Atrial Fibrillation in a General Japanese Population - The Hisayama Study. Circulation journal : official journal of the Japanese Circulation Society. 2021. 85. 8. 1365-1372
Jun Hata, Takuya Nagata, Satoko Sakata, Emi Oishi, Yoshihiko Furuta, Yoichiro Hirakawa, Takanori Honda, Daigo Yoshida, Takanari Kitazono, Toshiharu Ninomiya. Risk Prediction Model for Incident Atrial Fibrillation in a General Japanese Population - The Hisayama Study. Circulation journal : official journal of the Japanese Circulation Society. 2021. 85. 8. 1373-1382
Keisuke Yamasaki, Jun Hata, Tomomi Ide, Takuya Nagata, Satoko Sakata, Daigo Yoshida, Takanori Honda, Yoichiro Hirakawa, Toshiaki Nakano, Takanari Kitazono, et al. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study. Environmental health and preventive medicine. 2021. 26. 1. 47-47
Takaya Sasaki, Emi Oishi, Takuya Nagata, Satoko Sakata, Sanmei Chen, Yoshihiko Furuta, Takanori Honda, Daigo Yoshida, Jun Hata, Nobuo Tsuboi, et al. N-Terminal Pro-B-Type Natriuretic Peptide and Incident CKD. Kidney international reports. 2021. 6. 4. 976-985